Boston An independent LDT provider

Press releases

October 29, 2021

Invitation to Presentation of Immunovia’s Interim Report January – September 2021

Read press release
October 28, 2021

Immunovia receives Presidential Poster Award at the American College of Gastroenterology Annual Scientific Meeting

Read press release
October 25, 2021

Nomination Committee appointed for the 2022 Annual General Meeting of Immunovia AB (Publ)

Read press release
October 15, 2021 | REGULATORY

Immunovia Appoints New Chief Financial Officer

Read press release
September 14, 2021

The US based Pancreatic Cancer Action Network informs their members about Immunovia’s blood test IMMray™ PanCan-d

Read press release
September 13, 2021

Immunovia enters licensing agreement with JW BioScience for pancreatic cancer biomarkers

Read press release
September 3, 2021

Board member of Immunovia purchases shares in the company

Read press release
August 19, 2021 | REGULATORY

Immunovia Publishes Report for the Second Quarter 2021

Read press release
August 11, 2021

Invitation to Presentation of Immunovia’s Interim Report January – June 2021

Read press release
August 10, 2021

Immunovia Provides Updates on the Price for the IMMray[TM] PanCan-d Test in the US and Improved Test Performance in the Familial/Hereditary Risk Group

Read press release
August 4, 2021

Immunovia, Inc. Receives Approval to Begin Testing Patients for Pancreatic Cancer with the IMMray™ PanCan-d Test

Read press release
June 30, 2021

Immunovia, Inc. Receives Certificate of Registration – Clinical Laboratory Licensure Still Pending

Read press release
1 2 3 4 5 22